Publications
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial2014 | Third Faculty of Medicine
- Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study2004 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Incidence and therapy of brain metastases in patients with locally advanced non-small cell lung cancer2001 | Third Faculty of Medicine, First Faculty of Medicine
- A randomized phase II study with concurrent versus sequential radiochemotherapy in non-small cell lung cancerPublication without faculty affiliation
- Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
- Treatment of malignant pleural mesothelioma in the Czech Republic2019 | Faculty of Medicine in Pilsen, Central Library of Charles University
- First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer2017 | Central Library of Charles University
- Rare tumours in oncology2015 | Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- 5 Vzácné nitrohrudní nádory2015 | Third Faculty of Medicine
- Erlotinib in the treatment of advanced squamous cell NSCLC2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...